The Economic Evaluation of Rare Disease Medicines

Open

Oskar Skarayadi, Eka Kartika Untari, Peppy Octaviani, Niken Larasati

2024 Kemas Vol. 19 Issue 3 Article Cited by 1 Quartile

Abstract

Economic evaluation of rare diseases and orphan drugs has gained prominence among scientists, managers, and the general public. This challenging problem requires evaluation and analysis from a variety of perspectives. Economic assessment of technologies can support decision-making and resource allocation. The research objective describes and discusses several important issues when addressing economic evaluation in rare diseases and orphan drugs. The method used in this article review is searching the Pub-med, Scopus, and ScienceDirect databases using specific keywords for research articles published in English between 2016 and 2021. We found 537 studies that economically evaluated the cost of treating rare diseases. The selected studies met the eligibility criteria that had been established. To assess the quality of the selected papers, we used a 10-point checklist derived from Drummond’s criteria for economic evaluation. Seven papers were reviewed from the initial 20 articles that met the eligibility criteria, and 537 records were initially found across the three databases. The quality of the selected papers ranged from 70% to 100% in meeting Drummond’s 10-point checklist. The conclusion of this research is to consistently and continuously identify cost-effective and cost-saving solutions that may help achieve good clinical outcomes and reduce the burden of disease. Future research should focus on the clinical implementation of interventions along with accompanying economic evaluations. © 2024, Universitas Negeri Semarang. All rights reserved.

Affiliations

Faculty of Pharmacy, Jenderal Achmad Yani University, West Java, Cimahi, Indonesia; Pharmacy Department, Medical Faculty, Tanjungpura University, Pontianak, Indonesia; Pharmacy Department of Harapan Bangsa University, Central Java, Purwokerto, Indonesia; Bachelor Program of Pharmacy, Jenderal Achmad Yani University, Yogyakarta, Indonesia

Research at a Glance

Premium content — register to unlock

Research at a Glance

Register to unlock

Topics & SDG Alignment

Premium content — register to unlock

Topics & SDG Alignment

Register to unlock

Collaboration

Premium content — register to unlock

Collaboration

Register to unlock

Author Profile (Selected)

Premium content — register to unlock

Author Profile (Selected)

Register to unlock

References Overview

Premium content — register to unlock

References Overview

Register to unlock

Journal & Source

Premium content — register to unlock

Journal & Source

Register to unlock

Metadata & Integrity

Premium content — register to unlock

Metadata & Integrity

Register to unlock